基于癌毒驱动-态靶同调探讨肝癌伏邪-伏毒-癌毒病机演变规律与辨治策略OA

Primary hepatocellular carcinoma is one of the most prevalent malignancies worldwide,characterized by complex etiol‑ogy,rapid progression,and a serious threat to human health.Traditional Chinese Medicine(TCM)attributes the development of hepato‑cellular carcinoma to the interplay of stasis,toxin accumulation,and deficiency.In recent years,the"cancer toxin"theory has gained increasing attention;however,its dynamic formation and evolution remain inadequately elucidated.Based on classical TCM etiology and pathogenesis theory,integrated with modern diagnostic and therapeutic concepts,this study proposes an innovative"cancer toxin-driven and state-target synergy"treatment system.A three-stage dynamic model of pathogenesis transformation-latent pathogen,la‑tent toxin,and cancer toxin-was established to clarify the progression from damp-heat epidemic toxin latency to phlegm-stasis tumor formation and finally to toxin-fire-induced carcinogenesis.Correspondingly,a phased differentiation treatment strategy of"modulating internal state and consolidating the foundation,targeting and removing toxins"is proposed,aiming for comprehensive regulation throughout the disease course:prevention before onset,suppression during development,and stabilization amidst progression.This pa‑per systematically evaluates the efficacy of Shipi Xiaoji Formula-a TCM formula developed under this framework-through analysis of its formulation rationale,experimental mechanism verification,and clinical therapeutic synergy.The study provides theoretical and practical support for TCM-based differentiation and treatment of hepatocellular carcinoma,with promising implications for clinical ap‑plication.